Meridian Bioscience (VIVO) Posts Q1 EPS of $0.22, In-Line with Street; Reaffirms FY10 Guidance
Tweet Send to a Friend
Meridian Bioscience, Inc (NASDAQ: VIVO) reports Q1 EPS of $0.22, even with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
